Evaluation of the Effectiveness of Hepatitis B Vaccination in Children Aged 1 to 14 Years in Sulaimani City

Evaluation of the Effectiveness of Hepatitis B Vaccination in Children Aged 1 to 14 Years in Sulaimani City

Background and objectives:Hepatitis-B virus is one of the most serious and prevalent health problems. Vaccination against Hepatitis-B virus is the most effective way of preventing infection and transmission of the virus. The aim of this study was to assess the effectiveness of hepatitis-B virus vac...

Full description

Saved in:

Bibliographic Details
Main Authors:	Razhan Sabah Hassan, Ali Hattem Bayati
Format:	Article
Language:	English
Published:	Kurdistan Higher Council Of Medical Specialties 2023-04-01
Series:	Advanced Medical Journal
Subjects:	Antibody to hepatitis B surface antigen Hepatitis B virus Vaccination Sulaimani City
Online Access:	https://amj.khcms.edu.krd/index.php/main/article/view/172
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epidemiological Study of Hepatitis B, C and HIV Cases among the Foreigners Visiting Sulaimani City from 2013 Through 2016
by: Mohammed Omer Mohammed, et al.
Published: (2019-10-01)

Some results of studying the effectiveness of vaccination against hepatitis B
by: L. V. Rubis
Published: (2020-06-01)

Validation of quantitative hepatitis B virus DNA and hepatitis B e antigen titers in patients of chronic hepatitis B virus infection on entecavir therapy at tertiary care hospital
by: Diksha Budhani, et al.
Published: (2025-01-01)

Correlation between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients
by: Pete Maria, et al.
Published: (2023-01-01)

The Prevalence of Occult Hepatitis B Virus Infection among Hepatitis B Surface Antigen Sero-negative Blood Donors
by: Babandina Muhammad Musa 1, Ocheme Julius Okojokwu 2, Musa Saleh Makeri 3, Khadijat Toyi Musa 4, Amos Dangana 5, Maryam Aladodo 6, Saheed Adekola 7, Nura Muhammad Bunza 8, Zainab Usman-kanfani9, Clara Obiegue 10, Abbas M Babandina11 Musa Abidemi Muhibi 12,
Published: (2025-05-01)

Prospect of emerging treatments for hepatitis B virus functional cure
by: Rex Wan-Hin Hui, et al.
Published: (2025-02-01)

Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA
by: Hongyu Shen, et al.
Published: (2019-11-01)

The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus
by: Ling Ding, et al.
Published: (2025-12-01)

Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan
by: Rafail Ibragimov, et al.
Published: (2024-12-01)

Prevalence of hepatitis B virus infection and associated factors among adults intrafamilial household contacts attending antenatal care clinics in the Central Ethiopian region: from pregnant women index cases
by: Yilma Markos Larebo, et al.
Published: (2025-02-01)

Serologic and molecular characteristics of hepatitis B virus infection in vaccinated schizophrenia patients in China
by: Yiying Wang, et al.
Published: (2016-04-01)

Immune response to hepatitis B vaccine among north Iranian healthcare workers and its related factors
by: Farahnaz Joukar, et al.
Published: (2017-06-01)

National representative seroprevalence of viral hepatitis B, C, and D seromarkers in Ukraine, 2021
by: Olena Nesterova
Published: (2025-07-01)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
by: Shao-Juan Wang, et al.
Published: (2021-01-01)

Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus
by: V. S. Vysotskaya, et al.
Published: (2019-03-01)

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus
by: Ya-Li Zhang, et al.
Published: (2019-01-01)

Virological and morphological relationships in the phases of the immune control and reactivation in patients with chronic hepatitis B
by: I. A. Gabdrakhmanov, et al.
Published: (2016-02-01)

Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth
by: Ge Zhong, et al.
Published: (2025-02-01)

Reduction of the occurrence of occult HBV infection in infants by increasing the dose of hepatitis B vaccine: a large prospective cohort study
by: Yi Li, et al.
Published: (2020-01-01)

Predictive value of HBeAg titer dynamics for HBsAg clearance in pediatric chronic hepatitis B
by: Sukjin Hong, et al.
Published: (2025-04-01)

Seroprevalence of hepatitis B surface antigen and hepatitis B e antigen among childbearing-age women in Mianyang, China
by: Min Wang, et al.
Published: (2015-07-01)

Knowledge and behaviors about hepatitis B prevention and control among carriers of hepatitis B surface antigen
by: LI Siwen, ZHOU Tiantian, ZHANG Chao, ZHANG Dan, HU Weijun
Published: (2025-03-01)

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus
by: Tae Un Yang, et al.
Published: (2023-12-01)

Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus
by: Ying Lu, et al.
Published: (2021-01-01)

Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests
by: Moses P. Adoga, et al.
Published: (2010-04-01)

Evaluation of a recombinant DNA hepatitis B vaccine in a vaccinated Nigerian population
by: Moses P. Adoga, et al.
Published: (2010-08-01)

Low Hepatitis B vaccination coverage in New Delhi, India: urgent call for Universal Adult Hepatitis B vaccination
by: Kanica Kaushal, et al.
Published: (2025-04-01)

Hepatitis B knowledge and stigma in the United Arab Emirates
by: Hiba Jawdat Barqawi, et al.
Published: (2025-03-01)

Susceptibility to hepatitis B infection, hepatitis B/HIV co-infections and hepatitis B immunity in HIV-positive patients starting HAART in Durban, South Africa
by: F. M. Chonco, et al.
Published: (2019-04-01)

Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunities
by: Maria Buti, et al.
Published: (2025-12-01)

New Russian Trivalent Hepatitis B Vaccine (Bubo<sup>®</sup>-Unigep): Clinical Study Results
by: V. N. Borisova, et al.
Published: (2023-07-01)

Investigation of hepatitis B surface antibody levels among preschool and school-age children in Tonglu County, Zhejiang Province
by: YE Yang, et al.
Published: (2025-02-01)

The remodeling of B-cell subsets was correlated with the clearance of hepatitis B antigen during pegylated IFN α-2a therapy in CHB patients
by: Lei Tan, et al.
Published: (2025-12-01)

Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B
by: Bei Jiang, et al.
Published: (2025-12-01)

Immunogenicity assessment of Hepatitis A-VP1 and Hepatitis B surface antigen (HBsAg) fusion protein: a novel bivalent vaccine candidate
by: Mina Hannan, et al.
Published: (2025-07-01)

Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria
by: Michael O Iroezindu, et al.
Published: (2013-12-01)

Vaccination against viral hepatitis b in pediatric liver transplant recipients
by: V. I. Zhilkin, et al.
Published: (2018-01-01)

Pregnancy and Hepatitis B Virus Infection
by: Selma TOSUN
Published: (2016-12-01)

Booster immunity – diagnosis of chronic hepatitis B viral infection
by: Radka T Komitova, et al.
Published: (2019-03-01)

Genetic variants of hepatitis B virus in patients with chronic hepatitis B
by: E. A. Elpaeva, et al.
Published: (2015-11-01)